Celerion

Click any of the links below to read and download Celerion press releases.

Celerion appoints Dr. Bruce Morimoto as Executive Director, Applied Translational Medicine

Celerion Builds on Respiratory Capabilities With the Addition of an On-site Bronchoscopy Suite

Celerion is the First CRO Headquartered in the USA to Receive Full Accreditation from AAHRPP

Celerion announces expanded state-of-the-art ADME Suite in its Lincoln, Nebraska USA facility

Celerion and Ricerca Biosciences announces “The Biosimilars Alliance” to offer clients a more effective development path for biosimilars

Celerion First Early Stage Contract Research Organization to Adopt a Participant Verification System to Improve Participant Safety and Data Quality

Celerion scientist proud recipient of Scientific and Technological Achievement Award (STAA) from EPA

Celerion receives license enabling Investigational Medicinal Products (IMPs) to be imported directly to their GMP-licensed facility

Celerion appoints Dr. Raymond Farmen as Vice President of Global Bioanalytical Services

Celerion achieves major milestone of successfully analyzing over 25,000 platelet aggregation samples

Celerion announces highly automated ECG analysis enabling data delivery within 37 days from first patient dosed

Celerion receives ANVISA certification

Celerion awarded prestigious LEED® Green Building Certification

Celerion recognized as member of the UK Respiratory Therapeutic Capability Cluster

Celerion adds USP <797> Clean Room, enabling efficient execution of microtracer and microdosing studies

Celerion and BryanLGH Health System Form Alliance to Provide Dedicated Hospital Beds for Phase I Studies

Celerion launches electronic laboratory notebook, achieving major milestone toward 100% paperless laboratories

Celerion launches new Hybrid ECG Core Lab for Phase I clinics

Celerion acquires early stage clinical research operations from MDS Pharma Services